Akèy › Dyabèt › Tennessee › Memphis
Etid klinik pou Dyabèt nan Memphis, TN
5 etid pou Dyabèt ap chèche patisipan nan sit nan ak bò kote Memphis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Ap rekriteFaz 2/3
- Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Ap rekriteFaz 1/2
- Le Bonhuer Children's, Memphis
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Ap rekriteFaz 3
- Kailea Clinical Site, Memphis
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
Ap rekriteEtid obsèvasyon
- Methodist LeBonheur Healthcare, Memphis
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
Ap rekrite
- University of Tennessee Health Science Center/Regional One Health, Memphis
Etid Dyabèt nan lòt vil
- Boston, MA23 etid
- New York City, NY17 etid
- Houston, TX16 etid
- Chicago, IL15 etid
- Durham, NC14 etid
- Aurora, CO14 etid
- Baltimore, MD13 etid
- Philadelphia, PA12 etid
- Los Angeles, CA10 etid
- Washington, DC10 etid
- San Diego, CA10 etid
- Indianapolis, IN10 etid
Lòt etid nan Memphis
- Kansè (tout kalite)31 etid
- Kansè Poumon ki pa ti selil23 etid
- Kansè nan tete22 etid
- Kansè poumon18 etid
- Maladi selil fòs18 etid
- Leksemi limfoblastik egi16 etid
- Leksemi mieloïd egi15 etid
- Ensifizyans kadyak13 etid
- Kansè kolorektal11 etid
- Sarkom tisi mou11 etid
- Melanom11 etid
- Kansè pwostat11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.